Healthcare Equipment and Supplies
Company Overview of Presspart Manufacturing Limited
Presspart Manufacturing Limited manufactures deep-drawn and injection- molded components for pharmaceutical and other specialist industrial markets. The company specializes in metered dose inhalers and actuators. It offers pharmaceutical medical device components, such as metered dose inhaler (MDI) canisters; MDI actuators; and dispenser actuators for various containers and valves. The company also provides products for industrial applications, such as white goods components, solenoid valves, and rivets for use in a range of products, such as domestic appliances, including coffee machines and electric ovens, as well as non-safety critical vehicle applications, such as air conditioning units;...
Whitebirk Industrial Estate
Blackburn, BB1 5RF
Founded in 1970
Key Executives for Presspart Manufacturing Limited
Compensation as of Fiscal Year 2017.
Presspart Manufacturing Limited Key Developments
Cohero Health and H&T Presspart Introduce Their Connected MDI
Apr 5 16
Cohero Health and H&T Presspart announced the completion of their connected metered dose inhaler (eMDI). The eMDI incorporates electronics into a medication inhaler to passively track and communicate medication utilization. The device incorporates a sensor to track the date and time when medication is actuated, which is then stored in onboard memory, as well as shared wirelessly via Bluetooth. It works seamlessly with Cohero Health’s platform of connected devices and mobile applications, which actively engage and empower respiratory patients by tracking medication adherence and measuring lung function. The eMDI is the result of a multi-year development effort between Cohero Health and H&T Presspart. The relationship has resulted in production of functional devices, now readily available to the pharmaceutical industry. The companies believe the eMDI, which is available for demonstration, is the first functional connected MDI ever developed. Unique features include: Seamless integration into Cohero Health’s connected respiratory care platform; Onboard sensors to detect medication use as well as quality of medication administration (detection of proper inhaler actuation); On board electronic dose counting and display; Modular design enabling sensing and communication capabilities to be easily be applied to additional form factors; Compatibility with any valve and canister; and Lack of disruption to medication delivery geometry, reducing regulatory pathway and time to market. The eMDI represents an advancement of the Cohero Health platform, which is already the first and only respiratory disease management platform to offer tracking of both controller and rescue medications, along with clinically accurate lung function measurement via an FDA cleared mobile spirometer.
Similar Private Companies By Industry
Recent Private Companies Transactions
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking
Most Searched Private Companies
Sponsored Financial Commentaries